{"title":"Intravenous Immune Globulin Injections for Immunoglobulin Therapy","description":"\u003ch2\u003eIntravenous Immune Globulin (IVIG) – Immunoglobulin Therapy Explained\u003c\/h2\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eIntravenous Immune Globulin (IVIG)\u003c\/strong\u003e is a treatment where a purified solution of \u003cstrong\u003eantibodies (immunoglobulins)\u003c\/strong\u003e is infused directly into a patient’s vein. In simpler terms, it’s an \u003cstrong\u003e“antibody transfusion”\u003c\/strong\u003e. This therapy provides a person with a large pool of antibodies collected from the plasma of thousands of healthy donors. By delivering these antibodies intravenously, IVIG can \u003cstrong\u003eboost or modulate the immune system\u003c\/strong\u003e, and it’s used to treat a variety of conditions. The term “immunoglobulin therapy” refers to this use of antibody preparations (like IVIG) as medications to help patients who either \u003cstrong\u003elack sufficient antibodies or have immune systems that need regulation.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003ch2\u003eWhat Exactly Is in IVIG?\u003c\/h2\u003e\n\u003cp\u003eIVIG is made from \u003cstrong\u003ehuman plasma\u003c\/strong\u003e, the liquid part of blood. Plasma from many donors is pooled and processed to extract \u003cstrong\u003eImmunoglobulin G (IgG)\u003c\/strong\u003e, which is the main type of antibody in our blood. IgG is important for fighting infections – it recognizes bacteria, viruses, and other invaders and helps neutralize them or mark them for destruction. Each IVIG dose contains a broad spectrum of IgG antibodies reflecting immunity present in the donor population. In fact, \u003cstrong\u003eeach batch of IVIG contains antibodies from thousands of donors\u003c\/strong\u003e (often 1,000 to 15,000 people or more), ensuring a wide variety of antibodies. The manufacturing process includes steps to remove or inactivate viruses and bacteria, making the product as safe as possible. The final IVIG solution is usually a 5-10% concentration of IgG in water (with some stabilizing proteins or sugars), and it looks like a clear or pale yellow fluid.\u003c\/p\u003e\n\u003cp\u003eBecause IVIG comes from human donors, it provides \u003cstrong\u003epolyclonal antibodies\u003c\/strong\u003e – meaning many different antibodies against many antigens. It’s not a targeted, single-antibody treatment, but rather a collection of antibodies that together can cover a range of common infections. Some IVIG products contain trace amounts of IgA and IgM (other antibody types), but IgG is the primary component and the workhorse of the therapy.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"VODHU pdMy8\"\u003e\u003cstrong\u003eIVIG is a form of immunoglobulin therapy where concentrated antibodies from donor plasma are given through a vein\u003c\/strong\u003e. It serves two main purposes: \u003cstrong\u003eto replace antibodies in people who don’t have enough\u003c\/strong\u003e, and \u003cstrong\u003eto regulate the immune system in people whose immune responses are causing harm\u003c\/strong\u003e. This therapy has become a cornerstone for treating immunodeficiencies, allowing patients to lead much healthier lives than they would without antibodies. It’s also an important weapon against certain autoimmune and inflammatory conditions, often achieving results when other treatments fail. When you hear “immunoglobulin therapy,” IVIG is the prototypical example – a versatile, antibody-based treatment delivering passive immunity or immune modulation via intravenous injection.\u003c\/span\u003e\u003c\/p\u003e","products":[{"product_id":"hyperrho-s-d-immune-globulin-whs-250u-250-mcg-prefilled-syringes-10-box","title":"Rho (D) Immune Globulin (Human) HyperRHO S\/D Mini-Dose 250 IU (50 MCG) Prefilled Syringes 10\/Box (Rx)","description":"HyperRHO® S\/D Mini-Dose (RhO[D] immune globulin [human]) is recommended to prevent the isoimmunization of RhO(D)-negative women at the time of spontaneous or induced abortion of up to 12 weeks' gestation provided the following criteria are met: The mother must be RhO(D) negative and must not already be sensitized to the RhO(D) antigen. The father is not known to be RhO(D) negative. Gestation is not more than 12 weeks at termination.\n\u003cp\u003eHyperRHO S\/D is an immune globulin with a high level of preformed antibodies against rhesus (Rh)-positive blood cells.\u003cbr\u003eThe injection of an RHO(D) immune globulin provides a passive immunity for rapid immune protection and an acute response in high-risk situations.\u003cbr\u003eHyperRHO S\/D destroys any Rh-positive blood cells that may have entered the mother's bloodstream and prevents the mother's immune system from producing Rh-positive antibodies, thus protecting the baby from developing hemolytic disease.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eEach single-dose syringe of HyperRHO S\/D contains sufficient anti-RhO(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells.\u003cbr\u003e\u003cbr\u003eAntepartum and postpartum administration of a single dose of HyperRHO S\/D to susceptible Rh-negative women reduces the incidence of Rh isoimmunization to less than 0.1%.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEffective Protection\u003c\/strong\u003e\u003cbr\u003eHyperRHO S\/D destroys Rh-positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN.\u003cbr\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":39924081033288,"sku":"13533-0661-06","price":449.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Rho-_D_-Immune-Globulin-_Human_-HyperRHO-by-Grifols-Therapeutics.jpg?v=1725625340"},{"product_id":"hyperrho-s-d-whs-immune-globulin-full-dose-300u-300-mcg-prefilled-syringes-1-box","title":"HyperRHO S\/D WHS, Immune Globulin Full-Dose  300U (300 MCG) Prefilled Syringe 1\/Box (Rx) *Refrigerated*","description":"\u003cp\u003eHyperRHO® S\/D Full Dose (RhO[D] immune globulin [human]) is indicated for the prevention of Rh HDN and the prevention of isoimmunization in RhO(D)-negative individuals who have been transfused with RhO(D)-positive red blood cells.\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e* Refrigerated Item, Ships Next Day Air, SIGNATURE REQUIRED *\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eHyperRHO S\/D is an immune globulin with a high level of preformed antibodies against rhesus (Rh)-positive blood cells.\u003cbr\u003eThe injection of an RHO(D) immune globulin provides a passive immunity for rapid immune protection and an acute response in high-risk situations.\u003cbr\u003eHyperRHO S\/D destroys any Rh-positive blood cells that may have entered the mother's bloodstream and prevents the mother's immune system from producing Rh-positive antibodies, thus protecting the baby from developing hemolytic disease.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003eEach single-dose syringe of HyperRHO S\/D contains sufficient anti-RhO(D) to effectively suppress the immunizing potential of 15 mL of Rh-positive red blood cells.\u003cbr\u003e\u003cbr\u003eAntepartum and postpartum administration of a single dose of HyperRHO S\/D to susceptible Rh-negative women reduces the incidence of Rh isoimmunization to less than 0.1%.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEffective Protection\u003c\/strong\u003e\u003cbr\u003eHyperRHO S\/D destroys Rh-positive cells in the mother's body, prevents the mother's immune system from producing Rh-positive antibodies, and protects the baby from contracting HDN.\u003cbr\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":39924081590344,"sku":"13533-0631-02","price":189.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/RHO-Immune-Globulin-_Human_-300-mcg-by-Grifols-13533-0631-02.jpg?v=1724353748"},{"product_id":"xembify-immune-globulin-subcutaneous-human-klhw-20-injection-5-ml-requires-refrigeration","title":"Xembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL **Requires Refrigeration","description":"\u003cp\u003eXembify Immune Globulin Subcutaneous, Human – klhw 20% Injection 5 mL is a prescription medication used for the treatment of primary immunodeficiency (PI), a group of disorders in which the immune system is not functioning properly. It provides the body with antibodies that help to fight against infections. This medication is made from human plasma and is given as an injection under the skin (subcutaneously). It is also known as a subcutaneous immunoglobulin (SCIG) and is manufactured by Baxalta US Inc. Xembify is specifically formulated with the immune globulin klhw, which stands for kappa-free antibody in polysorbate. It is available in a 5 mL vial and contains 20% immune globulin.\u003c\/p\u003e\n\u003cp\u003eXembify Immune Globulin Subcutaneous, Human – klhw 20% (also known as Hizentra) is a medication used for replacement therapy in patients with primary immunodeficiency (PID). It is a solution of immunoglobulin G (IgG) antibodies that is injected under the skin (subcutaneously).\u003c\/p\u003e\n\u003cp\u003eIgG antibodies are a type of protein that is naturally produced by the immune system to help fight off infections. In patients with PID, their immune system does not produce enough IgG antibodies, putting them at a higher risk for infections.\u003c\/p\u003e\n\u003cp\u003eXembify works by replacing the deficient IgG antibodies in patients with PID. This helps to boost their immune system and protect them against infections. The IgG antibodies in Xembify are extracted from healthy human blood donors and purified to remove any potential impurities.\u003c\/p\u003e\n\u003cp\u003eOnce injected under the skin, Xembify is absorbed into the bloodstream and circulates throughout the body, providing protection against a wide range of bacteria, viruses, and other pathogens. It also helps to reduce the frequency and severity of infections in patients with PID.\u003c\/p\u003e\n\u003cp\u003eOverall, Xembify works to help improve and maintain the immune function of patients with PID. It is an important form of therapy that can greatly benefit these individuals and help them lead healthier lives.\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":40342539206728,"sku":"13533-0810-05","price":375.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Immune-Globulin-Treatments.jpg?v=1719923262"},{"product_id":"gamastan-immune-globulin-15-18-single-dose-vial-2-ml-requires-refrigeration-rx","title":"GamaSTAN Immune Globulin (Human) Treatment Single-Dose Vial * Refrigerated (RX)","description":"\u003ch3\u003eProven Passive Immunity for Hepatitis A, Measles, Rubella, and Varicella Exposure\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTrusted Protection, Fast Immunity—FDA-Approved Human Immune Globulin for Post-Exposure Prophylaxis\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003eWhen rapid, targeted immunological support is essential, medical professionals turn to \u003cstrong\u003eGamaSTAN Immune Globulin (Human) Treatment\u003c\/strong\u003e by Grifols Therapeutics. Developed to deliver immediate, passive antibody protection, GamaSTAN is the gold standard for post-exposure prophylaxis against \u003cstrong\u003eHepatitis A\u003c\/strong\u003e, \u003cstrong\u003eMeasles (Rubeola)\u003c\/strong\u003e, \u003cstrong\u003eRubella\u003c\/strong\u003e, and \u003cstrong\u003eVaricella (chickenpox)\u003c\/strong\u003e. Available in a convenient, premeasured \u003cstrong\u003esingle-dose vial\u003c\/strong\u003e, this injectable solution is carefully purified from human plasma and manufactured to the highest safety and efficacy standards.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eClinical Applications:\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eGamaSTAN Immune Globulin\u003c\/strong\u003e is a trusted, FDA-approved solution for healthcare professionals seeking to provide:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-Exposure Prophylaxis (PEP):\u003c\/strong\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHepatitis A\u003c\/strong\u003e: For susceptible individuals exposed to Hepatitis A virus (HAV)\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMeasles\u003c\/strong\u003e: For non-immune individuals exposed to confirmed measles (rubeola) cases\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eVaricella (Chickenpox)\u003c\/strong\u003e: For high-risk individuals exposed to varicella-zoster virus\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRubella\u003c\/strong\u003e: For immediate passive protection where rubella risk is high and vaccination is contraindicated\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTemporary Immune Support\u003c\/strong\u003e for immunocompromised patients unable to mount an adequate vaccine response\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProtection for International Travelers\u003c\/strong\u003e: Guarding against prevalent infectious diseases in high-risk areas\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eGamaSTAN\u003c\/strong\u003e delivers \u003cstrong\u003ehuman immune globulin\u003c\/strong\u003e with a proven efficacy and safety profile. As a plasma-derived medication, it supplies IgG antibodies to bridge the gap until the recipient’s immune system can respond or until vaccination becomes effective.\u003c\/p\u003e\n\u003ch3\u003eFeatures \u0026amp; Benefits\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmediate Passive Immunity:\u003c\/strong\u003e Provides rapid-acting immunoglobulin (IgG) antibodies for immediate post-exposure protection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFDA-Approved for Multiple Indications:\u003c\/strong\u003e Indicated for prophylaxis and protection following exposure to Hepatitis A virus, Measles, Rubella, and Varicella.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSingle-Dose, Ready-to-Use Vial:\u003c\/strong\u003e Ensures precise dosing, reduces waste, and supports safe administration in hospital, clinic, or travel medicine settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePurified Human Immune Globulin:\u003c\/strong\u003e Manufactured from carefully screened donors, virus-inactivation and removal processes ensure product safety.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eTrusted by Physicians and Hospitals:\u003c\/strong\u003e Backed by Grifols Therapeutics—a global leader in immunotherapy and plasma protein therapeutics.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDirections for Use\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdministration:\u003c\/strong\u003e For intramuscular injection only. Dosage depends on indication, patient body weight, and risk assessment. Refer to the prescribing information for detailed dosing guidelines.\u003c\/li\u003e\n\u003cli\u003eFor optimal protection, administer as soon as possible after exposure.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eProfessional Use Only:\u003c\/strong\u003e For use by or under the supervision of a healthcare professional.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWhy Choose GamaSTAN Immune Globulin by Grifols?\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eFDA-approved for multiple, life-threatening viral exposures\u003c\/li\u003e\n\u003cli\u003eFast-acting solution for urgent healthcare and public health needs\u003c\/li\u003e\n\u003cli\u003eManufactured using advanced purification and viral inactivation processes\u003c\/li\u003e\n\u003cli\u003ePrecise single-dose vials for reliable, controlled administration\u003c\/li\u003e\n\u003cli\u003eWidely used and trusted in hospitals, clinics, and travel medicine practices\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eImportant Safety Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eContraindications:\u003c\/strong\u003e Do not use in individuals with known severe allergic reactions to human immunoglobulins.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCautions:\u003c\/strong\u003e Use with care in patients with IgA deficiency or a history of anaphylaxis to immunoglobulins.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSide Effects:\u003c\/strong\u003e Rarely, may include injection site reactions, headache, fever, or allergic reactions.\u003c\/li\u003e\n\u003cli\u003eMonitor patients as per clinical guidelines when administering any biologic product.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eOrder Information\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003ePresentation:\u003c\/strong\u003e Single-dose vial for intramuscular injection\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Grifols Therapeutics\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"EcDrQ pdMy8\"\u003e\u003cstrong\u003eProtect your patients and community with the gold standard in passive immunity—GamaSTAN Immune Globulin (Human) Treatment by Grifols Therapeutics. Ensure immediate antibody protection for Hepatitis A, Measles, Varicella, and Rubella today.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"2 mL Vial","offer_id":40342564765768,"sku":"13533-0335-04","price":225.0,"currency_code":"USD","in_stock":true},{"title":"10 mL Vial","offer_id":40342564798536,"sku":"13533-0335-12","price":850.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/GamaSTAN-Immune-Globulin-Human-Treatment.jpg?v=1766423161"},{"product_id":"l-glutamine-oral-powder-5-gram-packets-60-box-rx","title":"L-Glutamine Oral Powder 5 Gram Packets 60\/Box (RX)","description":"\u003cp\u003eL-Glutamine Oral Powder 5 Gram Packets are a prescription strength supplement that contains a high concentration of the amino acid L-Glutamine. L-Glutamine is an essential amino acid that plays a crucial role in muscle growth and repair, immune system function, and intestinal health. This prescription strength powder is typically recommended for individuals who have a deficiency in L-Glutamine or who have certain medical conditions that may benefit from increased levels of this amino acid.\u003c\/p\u003e\n\u003cp\u003eL-Glutamine Oral Powder 5 Gram Packets by ANI Pharmaceuticals is a dietary supplement that contains the amino acid L-Glutamine. Each packet contains 5 grams of L-Glutamine powder, which can be mixed into liquids or food for easy consumption. L-Glutamine is one of the most abundant amino acids in the body and is involved in various important functions, such as protein synthesis and immune system support. This supplement may be beneficial for individuals looking to support their muscle and tissue health, as well as those with certain medical conditions that may benefit from increased L-Glutamine levels. It is important to consult with a healthcare provider before starting any new supplement regimen.\u003c\/p\u003e\n\u003cp\u003eL-Glutamine Oral Powder is a prescription medication that contains the amino acid L-Glutamine in a powdered form. It is used to treat conditions such as chemotherapy-induced mucositis, diarrhea associated with HIV, and inflammatory bowel disease.\u003c\/p\u003e\n\u003cp\u003eL-Glutamine is an essential amino acid, meaning that it is necessary for the proper functioning of the body but cannot be produced by the body itself. It is an important building block for proteins and plays a vital role in processes such as metabolism, cellular communication, and immune function.\u003c\/p\u003e\n\u003cp\u003eIn people with certain medical conditions, the body may not be able to produce enough L-Glutamine, leading to a deficiency. This can result in weakened immune function, tissue damage, and other adverse effects.\u003c\/p\u003e\n\u003cp\u003eThe prescription strength of L-Glutamine Oral Powder contains a higher concentration of the amino acid than supplements available over-the-counter. This higher concentration is necessary to address the specific medical conditions it is prescribed for.\u003c\/p\u003e\n\u003cp\u003eWhen taken orally, L-Glutamine Oral Powder is absorbed by the body and distributed to various tissues and cells. It can help to promote cellular repair and growth, aid in the maintenance of the intestinal lining, and support immune function. This can lead to a reduction in symptoms and an improvement in overall health and well-being.\u003c\/p\u003e\n\u003cp\u003eOverall, L-Glutamine Oral Powder prescription strength works by providing the body with a crucial amino acid that it may be lacking due to certain medical conditions. Regular use as directed by a healthcare provider can help improve symptoms and support the body's overall functioning.\u003c\/p\u003e","brand":"ANI Pharmaceuticals","offers":[{"title":"Default Title","offer_id":40375973314632,"sku":"70954-0417-20","price":1695.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/L-glutamine-Oral-Powder-by-ANI-Pharmaceuticals-70954-0417-20.jpg?v=1723982422"},{"product_id":"panzyga-10-2500-mg-immune-globulin-subcutaneous-human-ifas-10-solution-25-ml","title":"Panzyga 10% (2500 mg) (Immune Globulin Subcutaneous (Human)-ifas, 10% Solution) 25 mL","description":"\u003cp\u003ePanzyga 10% (2500 mg) is an intravenous immune globulin therapy used to manage immune deficiencies and autoimmune conditions. It is primarily prescribed for primary immunodeficiency (PI), where it provides essential antibodies to enhance the immune response and prevent infections. Additionally, Panzyga is used for treating chronic inflammatory demyelinating polyneuropathy (CIDP), helping to improve muscle strength and mobility by modulating immune system activity. The treatment is pivotal in supporting patients with compromised immune functions and reducing the frequency and severity of infections.\u003c\/p\u003e\n\u003cp\u003ePanzyga 10% (2500 mg) Immune Globulin Subcutaneous (Human) is used for the treatment of primary immunodeficiency (PI), boosting the immune system by providing necessary antibodies. It is also effective for chronic inflammatory demyelinating polyneuropathy (CIDP), helping to alleviate symptoms and improve muscle strength. Panzyga works by replacing or supplementing antibodies in patients with antibody deficiencies, thus offering protection against infections and supporting immune system function..\u003c\/p\u003e\n\u003cp\u003ePanzyga 10% is a premium intravenous immunoglobulin (IVIG) therapy proudly presented by Octapharma. Intended for patients with compromised immune systems, Panzyga 10% provides critical passive immunity that helps to fight against infections. This innovative treatment comes in a 25 mL vial containing 2500 mg of purified immune globulin for subcutaneous or intravenous administration. Sourced from healthy human plasma, Panzyga 10% conforms to impeccable standards of safety and effectiveness, fortifying patients’ immune defense with unmatched reliability.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eProduct Details and Features\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eConcentration:\u003c\/strong\u003e 10% Immunoglobulin G (IgG) solution\u003cbr\u003e\u003cstrong\u003eDosage Form: \u003c\/strong\u003e2500 mg in 25 mL (equivalent to 10% solution)\u003cbr\u003e\u003cstrong\u003eAdministration:\u003c\/strong\u003e Intravenous (IV) or Subcutaneous (SC)\u003cbr\u003e\u003cstrong\u003eSource: \u003c\/strong\u003eHuman plasma\u003cbr\u003e\u003cstrong\u003ePurity: \u003c\/strong\u003eMaximum removal of IgA, less than 50 mcg\/mL\u003cbr\u003e\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Octapharma, a leader in plasma derivatives\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMechanism of Action\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePanzyga functions by delivering a high concentration of Immunoglobulin G (IgG) antibodies, collected from the plasma of healthy donors, directly into the patient's circulation. These antibodies are broad-spectrum in their ability to neutralize pathogens such as bacteria and viruses, as well as modulating the immune response, providing its therapeutic effect in a variety of conditions like primary immunodeficiencies and autoimmune disorders. \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDirections for Use\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e1. Administration:\u003c\/strong\u003e Panzyga 10% can be administered intravenously or subcutaneously, depending on the indication and patient need. \u003cbr\u003e\u003cstrong\u003e2. Dosing:\u003c\/strong\u003e Dosage should be individualized based on patient condition, weight, and clinical response. \u003cbr\u003e\u003cstrong\u003e3. Preparation:\u003c\/strong\u003e Visually inspect for particulate matter and discoloration. Do not shake.\u003cbr\u003e\u003cstrong\u003e4. Infusion Rate:\u003c\/strong\u003e Begin at a slow rate with a gradual increase contingent upon patient tolerance.\u003c\/p\u003e\n\u003cp\u003eConsult healthcare professional guidelines for precise administration protocol.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Be aware of potential allergic reactions; contraindicated in individuals with known hypersensitivity to immunoglobulin preparations.\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBlood Glucose Monitoring:\u003c\/strong\u003e This product may affect measurements; specifically use monitoring systems PCA or PDMS.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRenal Dysfunction:\u003c\/strong\u003e Monitor renal function; cases of renal failure have been reported.\u003cbr\u003e\u003cstrong\u003e\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eThrombosis:\u003c\/strong\u003e Exercise caution for individuals with a history of thrombosis. Ensure adequate hydration.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eSide Effects\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eCommon side effects may include:\u003c\/em\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eMild to moderate headache\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eFatigue and fever\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eInfusion site reactions like redness or swelling\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eNausea\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHypertension\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eRare but serious reactions might include:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAnaphylaxis\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eThromboembolic events\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eHemolytic anemia\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAcute renal failure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e Disclaimer\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis information serves as a summary of the essential aspects regarding the administration and potential impact of Panzyga 10%. Comprehensive prescribing information, direction from healthcare professionals, and personalized patient assessments are necessary to optimize the safe and effective use of Panzyga 10%.\u003c\/p\u003e","brand":"Octapharma USA","offers":[{"title":"Default Title","offer_id":51678771347824,"sku":"68982-0822-02","price":799.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/Panzyga-10_-by-Pfizer.jpg?v=1731594400"},{"product_id":"hyperrab-rabies-vaccine-immune-globulin-injection-rapid-rabies-protection","title":"HyperRAB Rabies Vaccine Immune Globulin Injection Dosage Vial 1 mL (300 Units) (RX)","description":"\u003cp\u003eHyperRAB Rabies vaccine Immune Globulin Injection is a sterile solution containing human antibodies specifically targeted against the rabies virus. It is used as part of post-exposure prophylaxis for individuals who have potentially been exposed to rabies, such as through an animal bite or scratch, and who have not previously been vaccinated against rabies. HyperRAB Rabies vaccine provides immediate, but temporary, passive immunity by supplying ready-made antibodies that help neutralize the virus until the person’s own immune system can respond to the rabies vaccine, which is administered at the same time. The medication is given by infiltrating as much of the dose as possible into and around the wound, while any remaining amount is injected into a muscle away from the site where the rabies vaccine is given. HyperRAB Rabies vaccine is used only once at the beginning of rabies post-exposure treatment and should always be combined with a rabies vaccine for full protection. Common side effects may include soreness at the injection site, mild fever, or headache, while serious allergic reactions are rare.\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eHyperRAB\u003c\/strong\u003e is a high-potency rabies immune globulin (Human) formulated for immediate, short-term passive immunization against the rabies virus following suspected exposure. This solution contains 300 International Units (IU) per 1 mL, designed for precise and effective administration in rabies post-exposure prophylaxis (PEP).\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWhat It Is Used For\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHyperRAB\u003c\/strong\u003e is indicated for individuals who have been exposed, or potentially exposed, to rabies virus, typically via bites, scratches, or mucosal contact from a potentially rabid animal. It is always administered in conjunction with rabies vaccine as part of the recommended rabies PEP regimen.\u003c\/p\u003e\n\u003ch3\u003eImportant: CDC Guidelines for Use\u003c\/h3\u003e\n\u003cp\u003eAccording to the \u003cstrong\u003eCenters for Disease Control and Prevention (CDC)\u003c\/strong\u003e guidelines:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eRabies Immune Globulin (RIG)\u003c\/strong\u003e must be used in conjunction with rabies vaccine for previously unvaccinated individuals.\u003c\/li\u003e\n\u003cli\u003eRIG should be infiltrated around and into the wound site as soon as possible after exposure, followed by the rabies vaccine series.\u003c\/li\u003e\n\u003cli\u003eRIG should not be administered to persons who have been previously vaccinated against rabies.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eDosage and Administration\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStandard Dose:\u003c\/strong\u003e 20 IU\/kg body weight (infiltrate as much as possible into and around the wound; any remaining should be injected intramuscularly at a site distant from vaccine administration).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePreparation:\u003c\/strong\u003e Each vial contains 1 mL of solution (300 IU\/mL).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRoute:\u003c\/strong\u003e Infiltration into wound(s) and\/or intramuscular injection.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFrequency:\u003c\/strong\u003e Single administration at initiation of rabies PEP, \u003cstrong\u003enever after day 7\u003c\/strong\u003e of starting rabies vaccine, as it may interfere with the active immune response.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch4\u003eDirections\u003c\/h4\u003e\n\u003col\u003e\n\u003cli\u003e\u003cstrong\u003eInitiate therapy immediately after exposure.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eCalculate total volume required based on patient weight (20 IU\/kg).\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSlowly infiltrate as much of the total dose as anatomically feasible around the wound(s).\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eAdminister the remainder intramuscularly, distant from the rabies vaccine injection site.\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003ch3\u003eMechanism of Action\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eHyperRAB\u003c\/strong\u003e contains concentrated antibodies (IgG) specifically active against the rabies virus. It provides immediate passive immunity by neutralizing the virus at the wound site and in tissues before the patient’s own immune response develops following vaccination.\u003c\/p\u003e\n\u003ch3\u003eProduct Details and Features\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eNDC:\u003c\/strong\u003e 13533-0318-01\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eManufacturer:\u003c\/strong\u003e Grifols Therapeutics\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eSterile, preservative-free, single-use vial\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eHigh concentration (300 IU\/mL) for efficient administration\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eReady-to-use liquid formulation\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eGamma globulin fraction of human plasma\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eMaximum safety via donor screening, viral inactivation, and purification steps\u003c\/strong\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWarnings and Precautions\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHypersensitivity:\u003c\/strong\u003e Contraindicated in persons with known history of anaphylactic or severe systemic reaction to human immunoglobulin preparations.\u003c\/li\u003e\n\u003cli\u003e\u003cstrong\u003eDo NOT inject intravenously.\u003c\/strong\u003e\u003c\/li\u003e\n\u003cli\u003eUse with caution in individuals with IgA deficiency.\u003c\/li\u003e\n\u003cli\u003eRisk of transmitting infectious agents, including viruses and theoretically prions, cannot be completely eliminated due to human plasma source.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDo not exceed the recommended dose\u003c\/strong\u003e—excessive immunoglobulin can interfere with the efficacy of active rabies vaccination.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eSide Effects\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eCommon Adverse Reactions:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLocal reactions (pain, tenderness, erythema, bruising at injection site)\u003c\/li\u003e\n\u003cli\u003eSystemic symptoms (headache, malaise, low-grade fever, chills)\u003c\/li\u003e\n\u003cli\u003eAllergic reactions (urticaria, rash, rarely anaphylaxis)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eReport any severe or unusual reactions to your healthcare provider immediately.\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003eStorage\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eStore at 2–8°C (36–46°F). Do not freeze. Protect from light.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eHyperRAB 1 mL (300 IU\/mL) by Grifols Therapeutics\u003c\/strong\u003e is your trusted solution for immediate immune protection following potential rabies exposure, fully compliant with CDC rabies post-exposure guidelines. Ensure proper administration for optimal results and minimized risk. Always consult your healthcare professional for individualized PEP regimens.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan class=\"block _00hoS\"\u003e\u003cstrong\u003eOrder HyperRAB today for reliable, fast-acting rabies post-exposure prophylaxis!\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e","brand":"Grifols Therapeutics","offers":[{"title":"Default Title","offer_id":52279651860848,"sku":"13533-0318-01","price":999.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/files\/HyperRAB--human-rabies-immune-globulin.jpg?v=1747657318"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0996\/0350\/collections\/Immune-Globulin-Treatments.jpg?v=1748534642","url":"https:\/\/www.mountainside-medical.com\/collections\/immune-globulin-injections-infection-protection-immunity\/grifols-therapeutics+hrig-solution.oembed","provider":"Mountainside Medical","version":"1.0","type":"link"}